Artificial intelligence (AI) is beginning to transform the way we address cardiovascular disease, a condition claiming 1.7 million lives across Europe each year.
With projections indicating that over 100 million Europeans could be living with heart and circulatory diseases by 2050, the need for innovation has never been more urgent.
The latest research from the Joint Research Centre shows how AI is already making a difference in cardiovascular care:
➡️ Quantifying calcium deposits in the coronary arteries, one of the strongest predictors of future heart attacks, with the same accuracy as a specialist, in seconds rather than minutes.
➡️ Detecting hidden atrial fibrillation, a leading cause of stroke, from a routine ECG recorded during normal heart rhythm, before the patient ever has symptoms.
…& more!
These innovations enhance diagnostic accuracy, shorten response times, and improve patient outcomes. They should also support healthcare professionals, improve the care experience, and reduce costs for health systems.
Unlocking the full potential of AI in cardiovascular health requires addressing key challenges. Robust clinical trials are needed to validate these tools beyond initial studies, and many healthcare systems still lack the digital infrastructure to support widespread adoption.
Read the report here: Artificial intelligence in cardiovascular care: from promise to practice - Joint Research Centre
- Clibeanna
- healthcare and pharma
- Logáil isteach chun tráchtanna a phostáil